A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT00631150 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Levetiracetam (Keppra)

Sponsor

UCB Pharma